[Finding the right platelet anti-aggregant prescription for type-2 diabetes patients, according to the ADA 2003 criteria].
Raméntol Teys
Sandra
S
EAP La Gavarra, Institut Català de la Salut, SAP Baix Llobregat Centre, Unidad Docente de Medicina Familiar y Comunitaria Costa de Ponent, Cornellà de Llobregat, Barcelona, España.
Pujol Blaya
Vicenta
V
León de la Fuente
Mónica
M
León-Sanromà
María
M
D000328:Adult; D000368:Aged; D001241:Aspirin / Q000627:therapeutic use*; D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D016001:Confidence Intervals; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D011322:Primary Prevention; D012307:Risk Factors
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin